Option Care Health’s (OPCH) Market Outperform Rating Reiterated at Citizens Jmp

Citizens Jmp restated their market outperform rating on shares of Option Care Health (NASDAQ:OPCH) in a research report report published on Tuesday morning,Benzinga reports. Citizens Jmp currently has a $38.00 target price on the stock, up from their previous target price of $36.00.

Several other research firms have also weighed in on OPCH. Deutsche Bank Aktiengesellschaft increased their price target on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Morgan Stanley began coverage on shares of Option Care Health in a research report on Friday, October 17th. They set an “overweight” rating and a $35.00 target price for the company. JMP Securities set a $36.00 price target on shares of Option Care Health in a research note on Friday, October 31st. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. Finally, Stephens raised Option Care Health to a “strong-buy” rating in a report on Thursday, December 11th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $37.17.

Option Care Health Stock Up 1.7%

OPCH stock opened at $36.11 on Tuesday. The stock has a market cap of $5.73 billion, a P/E ratio of 28.66, a P/E/G ratio of 2.12 and a beta of 0.80. The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The stock’s fifty day simple moving average is $31.33 and its two-hundred day simple moving average is $29.51. Option Care Health has a 1-year low of $24.24 and a 1-year high of $36.18.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were purchased at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Institutional Trading of Option Care Health

A number of institutional investors have recently added to or reduced their stakes in OPCH. USA Financial Formulas purchased a new stake in Option Care Health in the second quarter worth approximately $26,000. Cornerstone Planning Group LLC raised its stake in shares of Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares in the last quarter. Advisory Services Network LLC bought a new stake in shares of Option Care Health in the 3rd quarter worth approximately $35,000. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health in the 2nd quarter valued at $37,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health in the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.